Breaking News

You are here » Indian-Commodity  :  Commodities  :  Other Commodities  :  Nymex crude extend gains despite dollar strength

01-Oct2016

Nymex crude extend gains despite dollar strength

Crude oil futures continued their upmove on Friday and extended their gains after OPEC members agreed on output cuts for the first time in eight years to stifle a two-year price slide. The cartel had agreed in principal on output cuts aimed at stabilizing crude oil prices above $50 a barrel heading into the New Year. Though, the prices suffered some setback with strengthening of dollar and as investors cashed in on crude's 6 percent one-day rise. Also, the United States, a non-OPEC country that is now the world's biggest oil producer, said it had little faith in this week's deal leading to higher prices in the long term.

Benchmark crude oil futures for November delivery gained $0.41 or 0.9 percent to close at $48.24 a barrel on the New York Mercantile Exchange. In London, Brent oil futures for November delivery declined by $0.19 or 0.3 percent to $49.05 a barrel on the ICE.


Related News

View all news

Nickel futures edge higher on improved demand

Nickel futures edged higher on MCX as participants enlarged their holdings on the back of improved demand from alloy-makers and other consuming industries at the spot market. The contract for October delivery......

Nickel futures edge higher on improved demand

Nickel futures edged higher on MCX as participants enlarged their holdings on the back of improved demand from alloy-makers and other consuming industries at the spot market. The contract for October delivery......

Coriander futures edge higher on improved demand

Coriander futures edged higher on NCDEX as participants built up fresh positions on the back of improved demand at the spot market. Further, tight supplies from major producing regions also fuelled the......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......